PATH classification: a proposal for patients with HNSCC treated with salvage surgery.

IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY European Archives of Oto-Rhino-Laryngology Pub Date : 2024-09-23 DOI:10.1007/s00405-024-08961-x
Albert Llansana, David Virós Porcuna, Rosselin Vasquez, Arnau Parellada, Cristina Valero, Anna Holgado, Xavier León
{"title":"PATH classification: a proposal for patients with HNSCC treated with salvage surgery.","authors":"Albert Llansana, David Virós Porcuna, Rosselin Vasquez, Arnau Parellada, Cristina Valero, Anna Holgado, Xavier León","doi":"10.1007/s00405-024-08961-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study is to propose a classification for patients with recurrent head and neck squamous cell carcinoma (HNSCC) treated with salvage surgery based on the location of the primary tumor and data commonly found in the pathological report of the resection.</p><p><strong>Methods: </strong>Retrospective study of 665 patients with HNSCC treated with a salvage surgery after a local and/or regional recurrence of the tumor.</p><p><strong>Results: </strong>We propose a new postoperative classification for patients with recurrent HNSCC treated with salvage surgery. PATH classification stratifies patients into 4 stages based on the glottic or non-glottic location of the primary tumor, the local and regional pathologic extension of the tumor, the status of the surgical margins, and the presence of lymph node metastases with extracapsular spread. The PATH classification was more homogeneous in the prognosis of patients included in each of its stages, and it had a better prognostic discrimination capacity between stages than the rpTNM classification. According to the PATH classification, the 5-year disease-specific survival was: PATH I (n = 306) 82.8%; PATH II (n = 119) 47.1%; PATH III (n = 202) 24.4%; PATH IV (n = 38) 3.7%. For the rpTNM classification, the 5-year disease-specific survival was: stage I (n = 119) 85.1%; stage II (n = 134) 68.4%; stage III (n = 111) 59.5%; stage IV (n = 301) 33.3%.</p><p><strong>Conclusion: </strong>The PATH classification for HNSCC patients with local and/or regional recurrence treated with salvage surgery had a better prognostic capacity than the rpTNM classification.</p><p><strong>Level of evidence: </strong>Level IV.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Archives of Oto-Rhino-Laryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00405-024-08961-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The aim of this study is to propose a classification for patients with recurrent head and neck squamous cell carcinoma (HNSCC) treated with salvage surgery based on the location of the primary tumor and data commonly found in the pathological report of the resection.

Methods: Retrospective study of 665 patients with HNSCC treated with a salvage surgery after a local and/or regional recurrence of the tumor.

Results: We propose a new postoperative classification for patients with recurrent HNSCC treated with salvage surgery. PATH classification stratifies patients into 4 stages based on the glottic or non-glottic location of the primary tumor, the local and regional pathologic extension of the tumor, the status of the surgical margins, and the presence of lymph node metastases with extracapsular spread. The PATH classification was more homogeneous in the prognosis of patients included in each of its stages, and it had a better prognostic discrimination capacity between stages than the rpTNM classification. According to the PATH classification, the 5-year disease-specific survival was: PATH I (n = 306) 82.8%; PATH II (n = 119) 47.1%; PATH III (n = 202) 24.4%; PATH IV (n = 38) 3.7%. For the rpTNM classification, the 5-year disease-specific survival was: stage I (n = 119) 85.1%; stage II (n = 134) 68.4%; stage III (n = 111) 59.5%; stage IV (n = 301) 33.3%.

Conclusion: The PATH classification for HNSCC patients with local and/or regional recurrence treated with salvage surgery had a better prognostic capacity than the rpTNM classification.

Level of evidence: Level IV.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PATH 分类:针对接受挽救手术治疗的 HNSCC 患者的建议。
目的:本研究旨在根据原发肿瘤的位置和切除病理报告中常见的数据,为接受挽救手术治疗的复发性头颈部鳞状细胞癌(HNSCC)患者提出一种分类方法:方法:对肿瘤局部和/或区域复发后接受挽救手术治疗的665例HNSCC患者进行回顾性研究:我们为接受挽救手术治疗的复发 HNSCC 患者提出了一种新的术后分类方法。PATH 分级法根据原发肿瘤的声门或非声门位置、肿瘤的局部和区域病理延伸、手术切缘状态以及是否存在囊外扩散的淋巴结转移将患者分为 4 期。与 rpTNM 分级相比,PATH 分级对各分期患者的预后判断更为一致,且各分期之间的预后鉴别能力更强。根据 PATH 分级,5 年疾病特异性生存率为PATH I(n = 306)82.8%;PATH II(n = 119)47.1%;PATH III(n = 202)24.4%;PATH IV(n = 38)3.7%。rpTNM分类的5年疾病特异性生存率为:I期(n = 119)85.1%;II期(n = 134)68.4%;III期(n = 111)59.5%;IV期(n = 301)33.3%:结论:对于接受挽救性手术治疗的局部和/或区域复发的HNSCC患者,PATH分类法的预后能力优于rpTNM分类法:证据等级:IV级
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.30
自引率
7.70%
发文量
537
审稿时长
2-4 weeks
期刊介绍: Official Journal of European Union of Medical Specialists – ORL Section and Board Official Journal of Confederation of European Oto-Rhino-Laryngology Head and Neck Surgery "European Archives of Oto-Rhino-Laryngology" publishes original clinical reports and clinically relevant experimental studies, as well as short communications presenting new results of special interest. With peer review by a respected international editorial board and prompt English-language publication, the journal provides rapid dissemination of information by authors from around the world. This particular feature makes it the journal of choice for readers who want to be informed about the continuing state of the art concerning basic sciences and the diagnosis and management of diseases of the head and neck on an international level. European Archives of Oto-Rhino-Laryngology was founded in 1864 as "Archiv für Ohrenheilkunde" by A. von Tröltsch, A. Politzer and H. Schwartze.
期刊最新文献
Correction: Long-term voice outcomes of medialization thyroplasty with adjustable implant for unilateral vocal fold paralysis. Correction: Management of Petrous Bone Cholesteatoma: The Gruppo Otologico Experience. Success and safety of endoscopic versus microscopic resection of temporal bone paraganglioma: a meta-analysis. Rhinitis medicomentosa and substance addiction. Heated humidified high-flow nasal cannula: a new conservative approach for neonatal nasal stenosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1